Placental residual evaluation by ultrasound contrast

JRCT ID: jRCTs021240030

Registered date:07/10/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: retained placenta
• Date of first enrollment: 07/10/2024
• Target sample size: 20
• Study type: Interventional
• Intervention(s): Administering ultrasound contrast agents for unapproved uses

Outcome(s)

• Primary Outcome: In cases where retained placenta is suspected by ultrasonography, we will examine whether (1) the correct diagnosis rate increases compared to normal ultrasound findings, and (2) whether differences in contrast density and contrast rate reflect the clinical course such as the amount of bleeding.
• Secondary Outcome: Evaluation of safety, including side effects, of ultrasound contrast agent administration to postpartum women

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: <= 50age old
• Gender: Female
• Include criteria: 20 puerperal women suspected of retained placenta on ultrasound

Exclude criteria

1) If consent cannot be obtained
2) egg allergy
3) heart disease or lung disease

Related Information

• Primary Sponsor: Miura Hiroshi
• Source(s) of Monetary Support: Akita University Hospital